Illumina grants and cost-saving options

Our commitment to genomic access is greater than ever with Illumina funding opportunities and innovative research collaborations

Overcoming funding challenges for scientific research

In challenging funding environments, we’re doing more to engage communities and expand research opportunities.

Genomic discoveries that can help solve the biggest challenges in health care can’t wait, even in the face of funding challenges. That is why Illumina is your partner for scientific advancements. With funding in uncertain times, we are dedicated to helping research communities continue to make discoveries through grants, financial solutions, partnerships, and scientific advocacy.

Ensuring genomics research progress with Illumina grants and venture funds

Supporting life-changing, innovative research is what drives our commitment to collaboration. Illumina offers a number of grants to help transform genomic discoveries into larger funded research programs. See how your big dreams can be built on small, but meaningful, steps whether you are in academia, industry, health care, or government.

Thumbnail

2024 Illumina epigenetics grant winner

Illumina proudly congratulates Isabel Cristina Céspedes, PhD, Associate Professor of Genetics at UNIFESP, Brazil, on winning the 2024 Illumina Epigenetics Research Grant on her aim to uncover potential off-target effects of allogeneic blood transfusions following heart surgery.

Learn how Illumina actively supports medical research conducted by third parties on Illumina products or technologies within our clinical areas of interest.

We are empowering researchers to push the boundaries of epigenetics. Through this grant, we're supporting innovative DNA methylation studies to advance scientific discoveries that impact health and disease.

See how we are committed to enabling groundbreaking research to increase the sustainability, productivity, and nutritional density of agricultural species, as well as a look at our past winners for this initiative.

Illumina and Signios Biosciences are teaming up to offer a research grant using NGS (next-generation sequencing)-based proteomics, a solution capable of detecting 9.5K unique human protein targets. The grant covers proteomic profiling along with use of the Illumina Connected Multiomics platform for tertiary analysis.

Illumina for Startups helps researchers grow their genomic innovation through business startups.

Illumina Ventures is an independently managed venture fund to bridge early-stage startups with access to capital, sequencing, mentorship, and fully equipped genomics lab capabilities.

Cost-saving services, products, and tools

To help offset research budget cuts, Illumina offers a number of cost-saving solutions such as financing options, service plans, and product selection tools.

Cost-saving solutions for your research budget

scientist pipetting with nextseq 1k 2k in background

Cost-saving tools and products

We offer a variety of tools and services to make your research more efficient. Learn how informatics analysis tools can efficiently optimize your research and how you can share and interpret your scientific data with greater ease. We also offer workflow and planning solutions to help guide you to the right products.

Informatics products

From samples and systems to analysis, see how to use integrated data with a comprehensive bioinformatics software platform built by genomics experts.

NGS is more attainable than ever

Learn how bringing NGS into your lab can cut costs, speed up workflows, and give you full control of your data, including scalable solutions to fit your needs.

Advance access to groundbreaking genomics

It takes a community to unlock the power of the genome. We offer partnerships with pharmaceutical and biotech industries, including startup funding programs for emerging companies to help accelerate breakthroughs in genomics.

Partnerships overview

Explore Illumina partnerships that help advance genomics by expanding access to next-generation sequencing (NGS) to pioneer new applications and technologies.

Illumina for Startups

Illumina for Startups is our way of accelerating innovation by partnering with leading venture capital investors and entrepreneurs to create, launch, and grow genomics startups.

Advancing genomic research with AI

Explore how AI is transforming genomic research, driving clinical insights, and enabling multiomic discoveries with industry partners.

Advocating for the present and future of genomic innovation

At Illumina, we recognize that research funding cuts affect all of us. That’s why we’re promoting innovation by advocating for science, research, education, and more, at all levels.

CEO Jacob Thaysen, PhD with student in San Diego

Federal research funding advocacy

Illumina is proactively working to ensure the continued progress of genomics and to promote broader access to NGS. By shaping public policies, including advocacy for government grants and funding, we are dedicated to supporting scientists and health care professionals who are making a difference each day, even in the face of research budget cuts. Our participation now is even more critical as we are working with policymakers to make scientific funding a priority. Our legislative priorities include:

  • Advancement of precision medicine
  • Adoption and reimbursement for genetic testing
  • Adoption and reimbursement for noninvasive prenatal testing
  • Adoption and funding for infectious disease surveillance

Building the future of genomics through education

STEM education

We know that next-generation sequencing also relies on next-generation scientists and professionals. Explore how Illumina is promoting resources for genomics across all education levels.

Thumbnail

Medical education grants

Illumina supports grants for independent medical education. Explore focus areas and other programs.

Promoting genomic access

Learn about the challenges and opportunities from leaders representing 12 genomics-centered US health systems and their solutions moving forward.

Illumina Solutions Centers

Learn about courses, demonstrations, workflows, and centers that can help guide you to solutions for Illumina sequencing and microarray applications.

Explore smarter tools and opportunities for streamlined, cost-efficient workflows

We are always finding ways to make your operational workflows easier and more cost-effective. From placing orders to tracking instrument performance and accessing software updates, our tools and platforms help you optimize valuable resources and reduce overhead. With Illumina, you can stay focused on making progress, even when funding gets tough.

See how signing up with MyIllumina streamlines your experience with intuitive tools that save time and reduce costs. In a climate of tightening budgets, MyIllumina helps you do more with less so you can keep your work moving forward.

reviewing MyIllumina on a laptop

See how we are empowering discovery and supporting communities

Thumbnail

How the NovaSeq X Series drives down research costs

See how companies like VectorY used the NovaSeq X Plus System to reduce sequencing times for high-throughput applications while also driving down costs.

Illumina in the community

Read how Illumina strives to positively impact the community with sustainable and compassionate stewardship.

Thumbnail

Polygenic risk scores grant winner

Illumina congratulates Emma Johnson, PhD, Assistant Professor of Psychiatry at Washington University School of Medicine, for her work on opioid use disorder in the context of acute and chronic postoperative pain.